Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR+48.1%
5Y CAGR-7.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+48.1%/yr
Annual compound
5Y CAGR
-7.6%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 62.74% |
| 2023 | -22.32% |
| 2022 | 31.23% |
| 2021 | 19.30% |
| 2020 | -48.32% |
| 2019 | 93.02% |
| 2018 | -0.70% |
| 2017 | -32.88% |
| 2016 | 17.40% |
| 2015 | -15.38% |